Hodgkin’s disease – Basic Information

Go back

Hodgkin’s disease, now commonly called Hodgkin lymphoma, is a type of cancer that develops in the lymphatic system, a vital part of the body’s immune defense network. This rare but highly treatable cancer typically begins in specific white blood cells and often first appears as painless swelling in the lymph nodes of the neck, chest, or other areas.

Understanding Hodgkin’s Disease

Hodgkin’s disease affects the lymphatic system, which includes organs, glands, and small bean-shaped structures called lymph nodes scattered throughout the body. This system is essential for protecting against infection and disease. The cancer starts in special white blood cells known as B lymphocytes, or B cells, which normally help fight off infections. When these cells undergo genetic changes at some point in life, they can begin to multiply uncontrollably, leading to Hodgkin lymphoma.

This condition is distinguished from other lymphomas by the presence of unusual cells called Reed-Sternberg cells, large abnormal cells that doctors look for when examining tissue samples under a microscope. These distinctive cells are surrounded by a mixture of non-cancerous inflammatory cells, creating a characteristic pattern that helps doctors make a diagnosis. The disease most commonly begins in lymph nodes located in the neck or the central chest area, though it can also develop in lymph nodes under the arms, in the groin, abdomen, or pelvis.

There are two main categories of this disease: classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Classic Hodgkin lymphoma accounts for approximately 95 percent of all cases and is further divided into four subtypes: nodular sclerosis, mixed cellularity, lymphocyte-rich, and lymphocyte-depleted. Each subtype has slightly different characteristics, though all are treated as highly curable forms of cancer.

How Common Is Hodgkin’s Disease?

Hodgkin lymphoma is considered a rare form of cancer. It affects roughly 3 in every 100,000 people each year globally. In the United States, between 8,500 and 9,000 new cases are diagnosed annually. Despite its rarity in the general population, Hodgkin lymphoma holds a particular distinction: it is one of the most common cancers affecting teenagers between the ages of 15 and 19, as well as young adults. This pattern of occurrence in younger people sets it apart from many other cancers that typically affect older populations.

The disease shows some interesting patterns across different groups. It is slightly more common in males than in females, though one subtype, nodular sclerosis Hodgkin lymphoma, affects young adult women more frequently. The condition can occur at any age, but it has two peak periods of diagnosis: the first is in early adulthood, typically between ages 20 and 39, and the second occurs later in life, in people aged 65 and older. Children can develop Hodgkin lymphoma, though this is less common, and when they do, they often have excellent treatment outcomes.

Compared to non-Hodgkin lymphoma, which is its counterpart in the lymphoma family, Hodgkin lymphoma is much less common. However, its relative rarity does not diminish its significance, especially given how successfully it can be treated when detected early. In 2015, approximately 574,000 people worldwide were living with Hodgkin lymphoma, showing that many individuals survive well beyond their initial diagnosis.

What Causes Hodgkin’s Disease?

The exact cause of Hodgkin lymphoma remains unknown to medical researchers. What is clear is that the disease develops when genes inside B lymphocytes undergo mutations or changes. These genetic alterations cause the cells to grow and multiply abnormally, eventually forming cancerous masses in lymph nodes and potentially spreading to other parts of the lymphatic system. However, scientists have not identified a single definitive trigger for these genetic changes.

There is strong evidence linking Hodgkin lymphoma to infection with the Epstein-Barr virus, often abbreviated as EBV. This virus, which belongs to the herpes family, is extremely common and causes infectious mononucleosis, commonly known as “mono.” Most people are exposed to EBV during childhood, often without developing any noticeable symptoms. However, when infection occurs during the teenage years, it can cause mono. Research has demonstrated that people who had mono as teenagers are approximately three times more likely to develop Hodgkin lymphoma later in life. About half of all Hodgkin lymphoma cases show evidence of EBV presence in the cancer cells, particularly in the mixed cellularity and lymphocyte-depleted subtypes.

Beyond viral connections, researchers have noted that Hodgkin lymphoma sometimes appears to run in families, suggesting a possible genetic predisposition. Having a parent or sibling with Hodgkin lymphoma increases a person’s risk of developing the disease. Additionally, people with compromised immune systems, whether from HIV/AIDS or from medications that suppress immunity, face a higher risk. Despite these associations, it’s important to understand that the exact mechanism by which these factors contribute to disease development is still being studied. Most people with these risk factors will never develop Hodgkin lymphoma, and many people who are diagnosed have no identifiable risk factors at all.

Risk Factors for Developing the Disease

Several factors have been identified that increase the likelihood of developing Hodgkin lymphoma, though having one or more risk factors does not guarantee that a person will develop the disease. Age is one significant factor. The condition most commonly affects people in two distinct age groups: young adults in their twenties and thirties, and older adults over 60 or 65. Being in these age ranges increases risk compared to other life stages.

Gender plays a modest role, with males having a slightly higher overall risk than females. However, this varies by subtype, as some forms of the disease show different patterns. Past infection with the Epstein-Barr virus, especially if it caused mononucleosis during adolescence, is another recognized risk factor. A family history of Hodgkin lymphoma also increases risk, with siblings and children of affected individuals facing higher chances of developing the condition.

People with weakened immune systems are more vulnerable to Hodgkin lymphoma. This includes individuals with HIV/AIDS, many of whom have been exposed to EBV. It also includes people taking immunosuppressive medications following organ transplants or for autoimmune diseases. Autoimmune conditions themselves, such as rheumatoid arthritis, lupus, Sjögren syndrome, or celiac disease, have been associated with increased risk. However, it’s crucial to remember that the vast majority of people with these conditions will never develop Hodgkin lymphoma.

⚠️ Important
Risk factors indicate increased probability, not certainty. Many people diagnosed with Hodgkin lymphoma have no identifiable risk factors, while many people with multiple risk factors never develop the disease. Risk factors help researchers understand patterns but cannot predict individual outcomes.

Recognizing the Symptoms

The most common first sign of Hodgkin lymphoma is painless swelling of one or more lymph nodes. These swollen nodes most frequently appear in the neck, but can also be noticed in the underarm area, groin, or above the collarbone. The affected lymph nodes typically feel rubbery and enlarged when touched, yet they cause no pain, which distinguishes them from lymph nodes swollen due to common infections. These lumps do not arise from any injury and do not disappear as quickly as swelling from minor infections would.

Beyond visible or palpable lumps, Hodgkin lymphoma can cause a constellation of symptoms that affect the whole body. Medical professionals call three specific symptoms “B symptoms” when they occur together: fever that cannot be explained by other causes, drenching night sweats that are so intense they soak through bedclothes and sheets, and unintentional weight loss. For weight loss to be considered significant, it typically means losing 10 percent or more of total body weight over six months without trying to lose weight through diet or exercise changes.

Many people with Hodgkin lymphoma experience persistent, overwhelming fatigue that goes beyond normal tiredness. This exhaustion doesn’t improve with rest and can last for many days or weeks. Some people develop very itchy skin, a condition called pruritus, which may become more intense after drinking alcohol or taking a bath. This itching can be severe enough to significantly impact quality of life and sleep.

Depending on where the lymphoma develops, other symptoms may arise. If cancer cells are present in the chest, people may experience chest pain, persistent coughing, or difficulty breathing, especially when lying down. This occurs because enlarged lymph nodes or tumors in the chest can press against the lungs or airways. When Hodgkin lymphoma affects the abdomen, it can cause abdominal pain, swelling, or a feeling of fullness. If it develops in bone, it may cause bone pain. Some people report that previously painless swollen lymph nodes become painful after consuming alcoholic beverages, though this is a less common symptom.

Prevention Strategies

Because the exact causes of Hodgkin lymphoma are not fully understood, there are no guaranteed methods to prevent the disease. Unlike some cancers that have clear preventable risk factors such as smoking or excessive sun exposure, Hodgkin lymphoma does not have similarly well-defined behavioral causes that can be avoided. However, understanding what is known about risk factors can help people make informed decisions about their health.

Since infection with the Epstein-Barr virus is associated with increased risk, avoiding EBV exposure could theoretically reduce risk. However, this is impractical in reality because EBV is extremely common worldwide, with most people becoming infected at some point during childhood or adolescence, often without knowing it. The virus spreads through saliva, which is why infectious mononucleosis is sometimes called “the kissing disease,” but it can also spread through coughing, sneezing, or sharing drinks and utensils. Complete avoidance of EBV exposure is nearly impossible in normal social life.

Maintaining a healthy immune system through general good health practices may offer some indirect benefit. This includes eating a balanced diet rich in fruits, vegetables, whole grains, and lean proteins; getting regular physical activity; maintaining a healthy weight; getting adequate sleep; managing stress; and avoiding smoking and excessive alcohol consumption. For people with HIV, taking antiretroviral medications as prescribed to keep the virus under control and maintain immune function is important, as it may reduce cancer risk along with many other health benefits.

There are no screening tests recommended for Hodgkin lymphoma in people without symptoms, unlike some other cancers such as breast, colorectal, or cervical cancer. This is because the disease is relatively rare, and screening large numbers of healthy people would not be practical or beneficial. Instead, early detection relies on people being aware of potential symptoms and seeking medical attention if they notice persistent, unexplained lymph node swelling or other concerning signs.

How the Disease Changes Body Function

Understanding what happens inside the body during Hodgkin lymphoma helps explain why symptoms occur and why treatment is necessary. In a healthy lymphatic system, lymphocytes circulate through lymph nodes and other lymphoid tissues, constantly surveying for foreign invaders like bacteria, viruses, and other threats. When they encounter something dangerous, they multiply rapidly to mount an immune response. Once the threat is eliminated, these cells normally stop multiplying and many die off in a controlled process.

In Hodgkin lymphoma, genetic mutations disrupt this normal control mechanism. B lymphocytes begin to multiply excessively without stopping, and they fail to die when they should. As these abnormal cells accumulate, they transform into the distinctive Reed-Sternberg cells and fill up lymph nodes, causing them to swell. The characteristic appearance under a microscope shows these large, abnormal cells scattered among a background of various inflammatory cells that the body has recruited in response to the malignancy.

As lymph nodes become packed with cancer cells, they enlarge but typically don’t hurt because the expansion happens gradually and doesn’t involve the acute inflammation that causes pain in infected lymph nodes. However, the mechanical pressure from very large nodes can cause discomfort or interfere with nearby structures. For example, enlarged lymph nodes in the chest can press against airways or blood vessels, causing breathing difficulties or swelling in the arms or face. Nodes in the abdomen can press on the stomach or intestines, causing feelings of fullness or digestive discomfort.

The disease affects more than just lymph nodes. As abnormal lymphocytes circulate through the bloodstream and lymphatic vessels, they can settle in other organs, including the spleen, liver, bone marrow, lungs, or bones. When cancer cells invade the bone marrow, they can interfere with the production of normal blood cells. This may lead to anemia, a condition where there aren’t enough red blood cells to carry oxygen efficiently, causing fatigue and weakness. Low white blood cell counts can increase infection risk, while low platelet counts can affect blood clotting.

The systemic symptoms of Hodgkin lymphoma—fever, night sweats, and weight loss—result from the body’s complex immune response to the cancer. Cancer cells and the immune cells surrounding them release various chemical messengers called cytokines. These substances can reset the body’s temperature regulation, leading to fevers and sweats. They can also affect metabolism and appetite, contributing to weight loss. The persistent fatigue experienced by many patients results from multiple factors: the cancer itself, anemia, the body’s ongoing immune response, poor sleep due to night sweats, and the psychological stress of dealing with a serious illness.

Ongoing Clinical Trials on Hodgkin’s disease

  • Study on Preventing Hypothyroidism in Patients with Medulloblastoma and Pediatric Lymphoma Using Levothyroxine During Radiation Therapy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Italy
  • Study on Triptorelin for Fertility Protection in Young Women and Teenagers Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas

    Not yet recruiting

    3 1 1
    Investigated drugs:
    Sweden
  • Study on the Safety of HSP-CAR30 Immunotherapy for Patients with Relapsed or Refractory CD30+ Hodgkin and Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Spain
  • Study of Tislelizumab, Gemcitabine, and Cisplatin for Patients with Relapsed or Refractory Hodgkin Lymphoma in Metabolic Complete Remission

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Denmark The Netherlands
  • Study on Early Response to Brentuximab Vedotin and Drug Combination for Advanced Hodgkin Lymphoma Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Denmark The Netherlands Poland Portugal Slovakia +1

References

https://www.mayoclinic.org/diseases-conditions/hodgkins-lymphoma/symptoms-causes/syc-20352646

https://my.clevelandclinic.org/health/diseases/6206-hodgkin-lymphoma

https://medlineplus.gov/hodgkinlymphoma.html

https://www.ncbi.nlm.nih.gov/books/NBK499969/

https://www.fredhutch.org/en/diseases/hodgkin-lymphoma/facts-resources.html

https://www.yalemedicine.org/conditions/hodgkin-lymphoma

https://www.nhs.uk/conditions/hodgkin-lymphoma/

https://en.wikipedia.org/wiki/Hodgkin_lymphoma

https://www.cancer.org/cancer/types/hodgkin-lymphoma/treating.html

https://www.mayoclinic.org/diseases-conditions/hodgkins-lymphoma/diagnosis-treatment/drc-20352650

https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq

https://www.nhs.uk/conditions/hodgkin-lymphoma/treatment/

https://cancer.ca/en/cancer-information/cancer-types/hodgkin-lymphoma/treatment

https://www.mskcc.org/cancer-care/types/lymphoma/treatment/hodgkin-lymphoma

https://my.clevelandclinic.org/health/diseases/6206-hodgkin-lymphoma

https://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/treatment

https://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/living-with/coping

https://www.cancer.org/cancer/types/hodgkin-lymphoma/after-treatment.html

https://www.hodgkinsinternational.com/the-five-most-important-things-to-do-as-a-long-term-survivor-of-hodgkins-lymphoma/

https://lymphoma-action.org.uk/about-lymphoma/living-and-beyond-lymphoma

https://bloodcancer.org.uk/understanding-blood-cancer/lymphoma/hodgkin-lymphoma/after-treatment/

https://pmc.ncbi.nlm.nih.gov/articles/PMC3224339/

https://www.healthline.com/health/thriving-with-hodgkin-lymphoma/diet-exercise-with-hodgkin-lymphoma

https://cancer.ca/en/cancer-information/cancer-types/hodgkin-lymphoma/supportive-care

https://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/living-with

FAQ

What is the difference between Hodgkin’s disease and Hodgkin lymphoma?

There is no difference—they are the same condition. The disease was originally called Hodgkin’s disease but is now more commonly referred to as Hodgkin lymphoma. The name was changed to reflect a better understanding that it is a type of cancer affecting the lymphatic system, similar to how other lymphomas are named.

Is Hodgkin lymphoma contagious?

No, Hodgkin lymphoma itself is not contagious and cannot be passed from person to person. While the Epstein-Barr virus, which is associated with increased risk of Hodgkin lymphoma, can spread through saliva, the cancer itself cannot be transmitted. Most people infected with EBV never develop Hodgkin lymphoma.

How is Hodgkin lymphoma different from non-Hodgkin lymphoma?

The main difference lies in the type of abnormal cells present. Hodgkin lymphoma contains distinctive Reed-Sternberg cells that can be seen under a microscope, while non-Hodgkin lymphoma does not. They also start in different types of white blood cells, behave differently, and require different treatment approaches. Hodgkin lymphoma is much less common than non-Hodgkin lymphoma.

Can Hodgkin lymphoma come back after successful treatment?

Yes, Hodgkin lymphoma can recur after treatment, though this happens in a minority of cases. Most people who complete treatment remain cancer-free. If the cancer returns, it is called relapsed or recurrent Hodgkin lymphoma, and additional treatments are available that can still be effective. Regular follow-up appointments help detect any recurrence early.

What should I do if I notice a swollen lymph node?

Most swollen lymph nodes are caused by common infections, not cancer, and will resolve on their own within a couple of weeks. However, you should see a healthcare provider if a swollen lymph node is painless, persists for more than two weeks, continues to grow, feels hard or rubbery, or is accompanied by fever, night sweats, or unexplained weight loss. Your doctor can determine whether further evaluation is needed.

🎯 Key takeaways

  • Hodgkin lymphoma is one of the most treatable and curable cancers, with 85% of patients becoming long-term survivors.
  • The disease often affects younger people, being one of the most common cancers in teenagers and young adults aged 15-39.
  • Painless swollen lymph nodes, especially in the neck, are the most common first sign, different from painful swelling caused by infections.
  • About half of Hodgkin lymphoma cases are associated with previous Epstein-Barr virus infection, the same virus that causes mononucleosis.
  • Reed-Sternberg cells are distinctive abnormal cells found in Hodgkin lymphoma that help doctors distinguish it from other types of lymphoma.
  • The disease has two peak ages of occurrence: one in early adulthood (20-39 years) and another after age 65.
  • Hodgkin lymphoma is relatively rare, affecting only about 3 in 100,000 people each year, and is much less common than non-Hodgkin lymphoma.
  • While there’s no way to prevent Hodgkin lymphoma, early detection through awareness of symptoms significantly improves treatment outcomes.